These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 1614747)
1. Changes in the CA 19-9 antigen and Lewis blood group with pulmonary disease severity in cystic fibrosis. Kane RE; Penny J; Walker K; Rubin BK; Wu J Pediatr Pulmonol; 1992 Apr; 12(4):221-6. PubMed ID: 1614747 [TBL] [Abstract][Full Text] [Related]
2. Tumor markers CA 19-9 and CA 195 are also useful as markers for cystic fibrosis. Wu JT; Olson J; Walker K J Clin Lab Anal; 1992; 6(3):151-61. PubMed ID: 1506983 [TBL] [Abstract][Full Text] [Related]
3. Elevated levels of serum mucin-associated antigen in adult patients with cystic fibrosis. Robinson CB; Martin WR; Ratliff JL; Holland PV; Wu R; Cross CE Am Rev Respir Dis; 1993 Aug; 148(2):385-9. PubMed ID: 8342902 [TBL] [Abstract][Full Text] [Related]
5. Infants and young children with cystic fibrosis have high levels of serum sialyl Lewis(a) antigen. Frates RC; Scott S; Hammond KB; Brooks JO; Richardson CJ; Roberts DD Pediatr Res; 1995 Apr; 37(4 Pt 1):460-4. PubMed ID: 7596685 [TBL] [Abstract][Full Text] [Related]
6. CA 19-9, CA 50 and elastase 1 as additional markers of cystic fibrosis. Uhlenbruck G; Scheuring U; Dienst C; Kaiser D; Roth B; Skopnik H Klin Padiatr; 1988; 200(2):89-95. PubMed ID: 3164430 [TBL] [Abstract][Full Text] [Related]
7. A serum test for cystic fibrosis using monoclonal antibody 19-9. Roberts DD; Monsein DL; Frates RC; Chernick MS; Ginsburg V Arch Biochem Biophys; 1986 Feb; 245(1):292-4. PubMed ID: 3456222 [TBL] [Abstract][Full Text] [Related]
8. Carcinoembryonic antigen and cystic fibrosis protein in blood from cystic fibrosis homozygotes and heterozygote carriers. Wilson GB; Burdash NM; Arnaud P; Monsher MT; Fudenberg HH Scand J Immunol; 1976; 5(6-7):829-36. PubMed ID: 824719 [TBL] [Abstract][Full Text] [Related]
9. Association between serum oncofetal antigens CA 19-9 and CA 125 and clinical status in patients with cystic fibrosis. Gronowitz E; Pitkänen S; Kjellmer I; Heikinheimo M; Strandvik B Acta Paediatr; 2003 Nov; 92(11):1267-71. PubMed ID: 14696845 [TBL] [Abstract][Full Text] [Related]
10. Expression of carbohydrate antigens in human pulmonary adenocarcinoma. Kawai T; Suzuki M; Kase K; Ozeki Y Cancer; 1993 Sep; 72(5):1581-7. PubMed ID: 8394200 [TBL] [Abstract][Full Text] [Related]
11. Relationship of carbohydrate antigen 19-9 and Lewis antigens in pancreatic cancer. Tempero MA; Uchida E; Takasaki H; Burnett DA; Steplewski Z; Pour PM Cancer Res; 1987 Oct; 47(20):5501-3. PubMed ID: 3308077 [TBL] [Abstract][Full Text] [Related]
12. [Blood group antigen expression in papillary carcinoma of the thyroid gland. An immunohistochemical and clinical study of expression of Lewis, ABO and related antigens]. Larena A; Vierbuchen M; Schröder S; Larena-Avellaneda A; Hadshiew I; Fischer R Langenbecks Arch Chir; 1996; 381(2):102-13. PubMed ID: 8649124 [TBL] [Abstract][Full Text] [Related]
13. Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis. Kim JS; Okamoto K; Rubin BK Chest; 2006 May; 129(5):1148-54. PubMed ID: 16685004 [TBL] [Abstract][Full Text] [Related]
14. CEA and CA 19-9 in benign pulmonary or mediastinal cystic lesions. Uyama T; Monden Y; Sumitomo M; Miura K; Kimura S J Surg Oncol; 1989 Jun; 41(2):103-8. PubMed ID: 2724976 [TBL] [Abstract][Full Text] [Related]
15. [Tumor-associated markers as organ-specific antigens of human seminal plasma. I. Immunologic studies]. Höller U; Uhlenbruck G; Dienst C; Dreessen C Z Hautkr; 1985 Jan; 60(1-2):147-56. PubMed ID: 3856977 [TBL] [Abstract][Full Text] [Related]
16. Changes in airway inflammation during pulmonary exacerbations in patients with cystic fibrosis and primary ciliary dyskinesia. Ratjen F; Waters V; Klingel M; McDonald N; Dell S; Leahy TR; Yau Y; Grasemann H Eur Respir J; 2016 Mar; 47(3):829-36. PubMed ID: 26585432 [TBL] [Abstract][Full Text] [Related]
17. Circulating tumor marker levels in advanced breast carcinoma correlate with the extent of metastatic disease. Colomer R; Ruibal A; Salvador L Cancer; 1989 Oct; 64(8):1674-81. PubMed ID: 2790682 [TBL] [Abstract][Full Text] [Related]